Search Results  for '059210.KQ'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Metabiomed Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Apr 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Metabiomed Co Ltd (059210-KQ)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

03 May 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Meta Biomed Co., Ltd.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

15 Apr 2016 Wright Reports 57 $75.00

Metabiomed Co Ltd: Downgraded to Risky

17 Dec 2015 Sadif Analytics Prime 3 $10.00

Metabiomed Co Ltd: Upgraded to Below Average

01 Jul 2015 Sadif Analytics Prime 3 $10.00

Metabiomed Co Ltd: Downgraded to Risky

03 Apr 2015 Sadif Analytics Prime 3 $10.00

Metabiomed Co Ltd: Upgraded to Average

22 Jan 2015 Sadif Analytics Prime 3 $10.00

Is Metabiomed Co Ltd Worth a Higher Bid?

02 Jan 2015 Sadif Analytics Prime 11 $25.00

Meta Biomed Co., Ltd. (059210) - Financial Analysis Review

Meta Biomed Co., Ltd. (059210) - Financial Analysis Review Summary Meta Biomed Co., Ltd. (Meta Biomed) is a medical dev...

13 Oct 2014 GlobalData 21 $125.00

Metabiomed Co Ltd: Downgraded to Below Average

09 Oct 2014 Sadif Analytics Prime 3 $10.00